Immunizing Older Individuals Requires Flexibility, Nuance
Pharmacy Times
JANUARY 2, 2023
When it comes to vaccination efforts, remember that patients 65 years or older are not a homogeneous group.
Pharmacy Times
JANUARY 2, 2023
When it comes to vaccination efforts, remember that patients 65 years or older are not a homogeneous group.
Pharma Phorum
JANUARY 3, 2023
The way pharmaceutical companies manage data carries inherent risks, as exemplified by the constant scandals about data breaches. Is there anything that can be done about this?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmaceutical Commerce
JANUARY 3, 2023
Collaboration aims to decrease environmental burden in the space.
PharmExec
JANUARY 18, 2023
Pete O'Heeron, founder, chairman, and CEO of FibroBiologics, explains the key principles that biotechnology companies should follow.
PharmaVoice
JANUARY 24, 2023
A longtime leader in the respiratory space, AstraZeneca has hammered another stake in the ground with its newest asthma treatment, Airsupra
Fierce Healthcare
JANUARY 23, 2023
Amazon Pharmacy rolls out service for unlimited generic drug prescriptions for $5 a month hlandi Mon, 01/23/2023 - 22:15
Pharmacy Times
JANUARY 10, 2023
Approximately half of patients with heart failure do not require an implantable monitoring device or do not qualify for thoracic monitoring.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Phorum
JANUARY 27, 2023
AstraZeneca’s revenue boost from COVID-19 therapy Evusheld looks set to be curbed early, as the FDA withdraws authorisation for the antibody on the grounds that it is ineffective against most subvariants now circulating in the US.
PharmExec
JANUARY 11, 2023
As new forms of cell and gene therapies continue to be developed, life sciences companies and payers need to find alternative ways to pay for these expensive treatments. Value-based contracts, though slow to gain traction so far, may provide the solution these groups are looking for.
PharmaVoice
JANUARY 3, 2023
Durect’s chief medical officer altered his retirement plans to take a leading role at the company, which is developing a treatment for severe alcohol-associated hepatitis
Pharmaceutical Technology
JANUARY 20, 2023
Pharmaceutical supply chains are extremely vulnerable to the effects of climate change and face many challenges from sourcing to distribution.
Pharmacy Times
JANUARY 20, 2023
Antibodies help neutralize the virus, though the levels decrease at the 6-month mark, data indicate.
NF2 BioSolutions
JANUARY 4, 2023
We are doing 2 fundraising challenges throughout the year this year and you can partake in any whenever you like, get everyone involved from mums, dads, kids, grandparents, aunts, uncles, neighbours, friends and work colleagues. HAVE FUN AND RAISE FUNDS FOR NF2 RESEARCH! CAKE BAKE & COFFEE.
Outsourcing Pharma
JANUARY 24, 2023
Research emerging from the University of Toronto found that using machine learning models was able to guide the design of long-acting drug formulations. Clinical Development
PharmExec
JANUARY 6, 2023
One company pursues a program for a technology they believe is a potential cure for Type 1 diabetes.
PharmaVoice
JANUARY 12, 2023
Merck, Bristol Myers Squibb and others are taking small R&D steps in space that could lead to giant leaps for patients
Fierce Healthcare
JANUARY 20, 2023
Dollar General pilots mobile clinics as it targets a bigger presence in healthcare hlandi Fri, 01/20/2023 - 18:25
Pharmacy Times
JANUARY 16, 2023
The head of the CAR T cell antibody can recognize and target the growth factor in its tumor microenvironment.
Fierce Pharma
JANUARY 26, 2023
BMS settles lawsuit with two fired employees who refused COVID vaccines kdunleavy Thu, 01/26/2023 - 14:30
Pharmaceutical Technology
JANUARY 22, 2023
In 2022, the FDA approved only 37 new medicines, an underwhelming number compared to 98 in 2018. However, while only around 34% of the approvals in 2018 were for orphan drugs, 54% new approvals in 2022 were for drugs to treat rare diseases.
PharmExec
JANUARY 11, 2023
The steps companies can take now to better protect themselves and their data.
PharmaVoice
JANUARY 19, 2023
The U.S. agency’s lower number of novel drug approvals followed several controversies surrounding a 2021 Alzheimer’s approval
Fierce Healthcare
JANUARY 19, 2023
UnitedHealthcare launches behavioral health coaching program for commercial plans pminemyer Thu, 01/19/2023 - 15:05
Pharmacy Times
JANUARY 3, 2023
In addition to the physical symptoms of long COVID, patients have reported vocal, verbal, and cognitive issues that disrupt their ability to communicate.
Fierce Pharma
JANUARY 9, 2023
JPM23, Day 1: BMS touts new launches as patent cliff looms; Regeneron's Eylea sales disappoint. esagonowsky. Mon, 01/09/2023 - 09:55
Pharma Phorum
JANUARY 6, 2023
Google and DeepMind have developed an artificial intelligence-powered chatbot tool called Med-PaLM designed to generate “safe and helpful answers” to questions posed by healthcare professionals and patients.
PharmExec
JANUARY 4, 2023
Baker spoke on topics ranging from pricing, access, the war for talent, and other key areas that are impacting pharma companies.
PharmaVoice
JANUARY 4, 2023
How charitable firms such as Advancium are helping to right the market wrongs of drug development
Fierce Healthcare
JANUARY 18, 2023
New Jefferson Health program enables clinical, academic nurses to partner on research agliadkovskaya Wed, 01/18/2023 - 14:16
Pharmacy Times
JANUARY 19, 2023
Data from a randomized clinical trial supports previous clinical findings on SGLT2 inhibitors and their ability to slow the progression of chronic kidney disease.
Fierce Pharma
JANUARY 25, 2023
Moderna now in the crosshairs of Sens. Warren, Welch over price tag for COVID vaccine kdunleavy Wed, 01/25/2023 - 13:16
Pharma Phorum
JANUARY 27, 2023
Johnson & Johnson has been cleared to continue a lawsuit filed last year against drug benefit programme SaveOnSP, which claims it defrauded a payment assistance programme for patients out of “at least $100 million.”
PharmExec
JANUARY 18, 2023
Author Deepa Purushothaman discusses the progress of women and women of color in corporate America.
PharmaVoice
JANUARY 11, 2023
The chief strategy officer of Form Bio is harnessing the new company’s computing power and bioinformatics to spur a genomic revolution
Fierce Healthcare
JANUARY 18, 2023
Healthcare ranked lowest for employee satisfaction, Qualtrics survey finds aburky Wed, 01/18/2023 - 16:40
Pharmacy Times
JANUARY 17, 2023
Vaccination provides an opportunity to prevent and treat herpes simplex virus infection.
Fierce Pharma
JANUARY 17, 2023
CDC probes possible safety risk for Pfizer's new COVID shot, sees no need to change vaccine practices. zbecker. Tue, 01/17/2023 - 11:49
Let's personalize your content